3-[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]-N-(4-fluorophenyl)propanamide
C27H20ClFN4O3 — CID 123131739
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]-N-(4-fluorophenyl)propanamide
3-[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]-N-(4-fluorophenyl)propanamide (PubChem CID 123131739) has the molecular formula C27H20ClFN4O3 and a molecular weight of 502.93 g/mol. Its IUPAC name is 3-[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]-N-(4-fluorophenyl)propanamide.
Molecular Properties
| Compound Name | 3-[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]-N-(4-fluorophenyl)propanamide |
|---|---|
| PubChem CID | 123131739 |
| Molecular Formula | C27H20ClFN4O3 |
| Molecular Weight | 502.93 g/mol |
| Exact Mass | 502.12 |
| IUPAC Name | 3-[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]-N-(4-fluorophenyl)propanamide |
| SMILES | O=C(CCc1cn(Cc2ccc3oc(-c4ccc(Cl)cc4)cc(=O)c3c2)nn1)Nc1ccc(F)cc1 |
| InChI | InChI=1S/C27H20ClFN4O3/c28-19-4-2-18(3-5-19)26-14-24(34)23-13-17(1-11-25(23)36-26)15-33-16-22(31-32-33)10-12-27(35)30-21-8-6-20(29)7-9-21/h1-9,11,13-14,16H,10,12,15H2,(H,30,35) |
| InChIKey | IOYPWVDSGKUZTM-UHFFFAOYSA-N |
| XLogP | 5.46 |
| TPSA | 90.02 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 502.93 |
| LogP ≤ 5 | 5.46 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123131739 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.